General Partner Inc’s Zimmer Biomet ZBH Stock Holding History

General Partner Inc’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-325	Closed	-$41.4K	–	237
2022 Q4	$41.4K	Buy	+325	New	+$37.7K	0.04%	154

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

General Partner Inc's ZBH Position: Q1 2023 in Review

General Partner Inc sold out of Zimmer Biomet (ZBH) in Q1 2023, closing a stake of 325 shares — an estimated $41.4K sold.

General Partner Inc first reported a position in ZBH in Q4 2022 and held it in 1 quarter. The position peaked at $41.4K in Q4 2022. 993 funds tracked by Wall St. Rank hold ZBH as of Q1 2023.

General Partner Inc reported no remaining Zimmer Biomet position as of Q1 2023 after selling out during the quarter.
General Partner Inc sold 325 Zimmer Biomet shares in Q1 2023, an estimated $41.4K.
General Partner Inc first reported a position in Zimmer Biomet in Q4 2022 and held it in 1 quarter.
General Partner Inc's Zimmer Biomet position peaked at $41.4K in Q4 2022.
993 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2023.

Based on General Partner Inc's 13F filing for Q1 2023, filed 7 Apr 2023.